Sling-Fiber Preservation vs. Conventional POEM for Achalasia
(SFP-POEM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two methods of performing peroral endoscopic myotomy (POEM) for individuals with achalasia, a condition that makes swallowing difficult. Researchers aim to determine if preserving certain muscle fibers during the procedure can reduce the risk of developing acid reflux afterward. One group will undergo the standard POEM (Conventional POEM), while the other will receive a modified version that preserves specific muscle fibers (Sling Fiber-Preserving POEM). This study suits adults diagnosed with achalasia who can undergo endoscopy and consent to participate. As an unphased trial, it offers a unique opportunity to contribute to medical knowledge and potentially improve future treatment options for achalasia.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Sling Fiber-Preserving POEM (SFP-POEM) is generally safe and successful, with about a 90% success rate. This method may also reduce the risk of severe erosive esophagitis, which involves damage and inflammation of the esophagus lining, compared to traditional methods. By avoiding the cutting of certain muscle fibers in the stomach, SFP-POEM seems to help prevent reflux problems. In contrast, studies indicate that while the conventional POEM treatment is technically successful, about 49% of patients may experience reflux esophagitis, which means irritation or damage to the esophagus after the procedure. Both treatments have been studied for safety, but SFP-POEM might have an advantage in reducing some side effects.12345
Why are researchers excited about this trial?
Researchers are excited about Sling Fiber-Preserving POEM for achalasia because it offers a unique approach by selectively preserving the gastric sling fibers. Unlike conventional POEM, which involves cutting both circular and sling muscle fibers, this new method aims to spare the sling fibers, potentially reducing side effects and improving recovery. This technique employs a double scope method to ensure precision, which could lead to better long-term outcomes for patients. By targeting the right of the second penetrating vessel, it innovates on the traditional approach, promising a more refined treatment option for achalasia sufferers.
What evidence suggests that this trial's treatments could be effective for achalasia?
This trial will compare two procedures for treating achalasia: Conventional POEM and Sling Fiber-Preserving POEM (SFP-POEM). Studies have shown that the traditional POEM procedure effectively treats achalasia, a condition that makes swallowing difficult, with less invasiveness. Although it provides excellent symptom relief, it often results in a high rate of acid reflux, where stomach acid irritates the esophagus. Research suggests that SFP-POEM, which participants in this trial may receive, might reduce the risk of severe reflux while maintaining effectiveness. One study found that preserving the sling fibers during the procedure can reduce severe erosive esophagitis (a serious form of reflux) and has a success rate of 90%. This suggests that SFP-POEM could be a safer option with fewer side effects related to acid reflux.12346
Who Is on the Research Team?
Jason Samarasena, MD, MBA
Principal Investigator
University of California, Irvine
Are You a Good Fit for This Trial?
This trial is for adults with achalasia, a condition that affects the esophagus and causes difficulty swallowing. Participants should not have other complications like severe reflux esophagitis or previous treatments for achalasia. They must be able to undergo endoscopy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either conventional POEM or sling fiber-preservation POEM procedure
Initial Follow-up
Participants are monitored for reflux esophagitis and other outcomes
Extended Follow-up
Participants are monitored for ongoing reflux symptoms and PPI use
What Are the Treatments Tested in This Trial?
Interventions
- Conventional POEM
- Sling Fiber-Preserving POEM
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Irvine
Lead Sponsor
Hoag Memorial Hospital Presbyterian
Collaborator
Vancouver General Hospital
Collaborator
Cedars-Sinai Medical Center
Collaborator
University of Ottawa
Collaborator